Patent ID: 8497299

Claim:
A pharmaceutical composition comprising, as an active ingredient, a cannabinoic quinone or an enantiomer thereof, wherein the cannabinoic quinone is a compound of formula (V): wherein X is an oxygen atom; p is zero when X is oxygen; R 1 is H or C 1 -C 5 alkyl; R 2 designates a methylene group optionally substituted with up to two alkyl groups, wherein R 2 with substituents comprises up to 5 carbon atoms; R 3 is optionally branched C 1 -C 10 alkyl or optionally branched C 1 -C 10 alkenyl, wherein the alkyl or alkenyl are optionally substituted with hydroxyl, alkoxyl, halo (fluoro, chloro, bromo, iodo), thio, amino, or cyano; and R 4 is optionally branched C 1 -C 5 alkyl or optionally branched C 1 -C 5 alkenyl, optionally substituted with hydroxyl, halo (fluoro, chloro, bromo, iodo), thio, amino, and cyano.